Annals of Clinical Microbiology and Antimicrobials · 2008 · 172 citations · 9 references
Veterinary MedicineInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingEmpiric Antimicrobial TherapyResistance EpidemiologyResistance SurveillanceUrinary Tract InfectionsAntibiotic Susceptibility Data AnalysisAntimicrobial Resistance In Urinary Tract InfectionsAntimicrobial Resistance PatternsDrug Resistance PatternsEscherichia ColiExtended-spectrum Beta-lactamase ProductionNosocomial Urinary Tract InfectionsUrinary Tract Infection Antibiotic Therapy
BACKGROUND: Escherichia coli is the commonest cause of community and nosocomial urinary tract infection (UTI). Antibiotic treatment is usually empirical relying on susceptibility data from local surveillance studies. We therefore set out to determine levels of resistance to 8 commonly used antimicrobial agents amongst all urinary isolates obtained over a 12 month period. METHODS: Antimicrobial susceptibility to ampicillin, amoxicillin/clavulanate, cefalexin, ciprofloxacin, gentamicin, nitrofurantoin, trimethoprim and cefpodoxime was determined for 11,865 E. coli urinary isolates obtained from community and hospitalised patients in East London. RESULTS: Nitrofurantoin was the most active agent (94% susceptible), followed by gentamicin and cefpodoxime. High rates of resistance to ampicillin (55%) and trimethoprim (40%), often in combination were observed in both sets of isolates. Although isolates exhibiting resistance to multiple drug classes were rare, resistance to cefpodoxime, indicative of Extended spectrum beta-lactamase production, was observed in 5.7% of community and 21.6% of nosocomial isolates. CONCLUSION: With the exception of nitrofurantoin, resistance to agents commonly used as empirical oral treatments for UTI was extremely high. Levels of resistance to trimethoprim and ampicillin render them unsuitable for empirical use. Continued surveillance and investigation of other oral agents for treatment of UTI in the community is required.
9
Hüsnü Pullukçu, Meltem Taşbakan, Oğuz Reşat Sipahi et al. · International Journal of Antimicrobial Agents · 2006 · 168 citations
Juan-Ignacio Alós, M. Gobernado Serrano, J.L. Gómez‐Garcés et al. · Clinical Microbiology and Infection · 2005 · 142 citations